Makroo Raj Nath, Rajput Saroj, Agarwal Soma, Chowdhry Mohit, Prakash Bindu, Karna Prashant
Department of Immunohematology, Institution Indraprastha Apollo Hospitals, New Delhi, India.
Department of Transfusion Medicine, Institution Indraprastha Apollo Hospitals, New Delhi, India.
Asian J Transfus Sci. 2018 Jan-Jun;12(1):17-20. doi: 10.4103/ajts.AJTS_4_17.
Alloantibodies may be detected in blood donors who have either been transfused previously or female donors with previous obstetric events. These antibodies can occasionally cause severe transfusion reaction, if a large amount of plasma or whole blood is transfused, as in massive transfusions and pediatric patients.
The present study aims to assess the prevalence of red cell antibodies in healthy blood donors at a tertiary care hospital-based blood bank in India.
A total of 82,153 donor samples were screened for irregular red cell antibodies between January 2012 and December 2015 at the Department of Transfusion Medicine, Indraprastha Apollo Hospitals, New Delhi. Antibody screening was performed by solid phase method using Immucor Capture-R ready screen (pooled cells) on fully automated immunohematology analyzer Galileo Neo (Immucor Inc., Norcross, GA, USA). Positive tests were further confirmed using Capture-R ready screen (4 cell panel). Advanced investigations to identify the antibody/ies were performed on confirmed positive samples. Antibody identification was conducted using various cell panels (Immucor Capture-R Ready-ID, Panocell-10, Ficin Treated). An advanced technique such as adsorption and elution was performed as per requirement.
Screening with pooled cells and 4 cell panel was positive in 227 donors (0.27%), 150 of these donors had autoantibodies, 1 had autoantibodies with underlying alloantibody anti-Jk (0.001%), and 76 had alloantibodies (0.09%) alone in their plasma. Anti-M was the most common antibody (43 donors) identified, followed by anti-D (21 donors). Anti-N was detected in 4; anti-Jk, anti-C, and anti-E in two donors each followed by anti-P1 and anti-Le in 1 donor.
Antibodies against red cells can be present in healthy donors detection of which is important in providing safe blood to the patient. The prevalence of red blood cell antibody in healthy donors in this study was found to be 0.27%, while the prevalence of alloantibodies was 0.09%. The majority of alloantibodies were anti-M (56.57%) and anti-D (27.63%).
在既往接受过输血的献血者或既往有产科病史的女性献血者中可能检测到同种抗体。如果大量输注血浆或全血,如在大量输血和儿科患者中,这些抗体偶尔会引起严重的输血反应。
本研究旨在评估印度一家三级护理医院血库中健康献血者红细胞抗体的流行情况。
2012年1月至2015年12月期间,在新德里英迪拉普拉萨德阿波罗医院输血医学科,共对82153份献血者样本进行了不规则红细胞抗体筛查。采用固相法,使用Immucor Capture-R ready screen(混合细胞)在全自动免疫血液分析仪Galileo Neo(Immucor公司,美国佐治亚州诺克罗斯)上进行抗体筛查。阳性检测结果进一步使用Capture-R ready screen(4细胞板)进行确认。对确认的阳性样本进行进一步检测以鉴定抗体。使用各种细胞板(Immucor Capture-R Ready-ID、Panocell-10、经胰蛋白酶处理)进行抗体鉴定。根据需要进行吸附和洗脱等先进技术操作。
混合细胞和4细胞板筛查中,227名献血者呈阳性(0.27%),其中150名献血者有自身抗体,1名献血者有自身抗体且伴有潜在的同种抗体抗-Jk(0.001%),76名献血者血浆中仅有同种抗体(0.09%)。抗-M是最常见的抗体(43名献血者),其次是抗-D(21名献血者)。检测到4名献血者有抗-N;2名献血者各有抗-Jk、抗-C和抗-E,其次是1名献血者有抗-P1和抗-Le。
健康献血者中可能存在抗红细胞抗体,检测这些抗体对于为患者提供安全血液很重要。本研究中健康献血者红细胞抗体的流行率为0.27%,同种抗体的流行率为0.09%。大多数同种抗体为抗-M(56.57%)和抗-D(27.63%)。